According to Tarsus Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โฌ0.12 Billion. In 2023 the company made a revenue of โฌ15.78 Million a decrease over the revenue in the year 2022 that were of โฌ24.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | โฌ0.11 B | 651.14% |
2023 | โฌ15.78 M | -34.42% |
2022 | โฌ24.06 M | -52.21% |
2021 | โฌ50.35 M | |
2020 | N/A |